Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs NTAP✓SelectedUSD · NTAPMRNA vs NTAP performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs NTAP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
NTAP return
+104.1%
Excess return
-135.1%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioNTAPExcessAlpha
1D-2.2%-7.4%+5.2%-0.3%
7D-12.7%-13.1%+0.4%-9.5%
30D-20.7%-27.4%+6.8%-14.2%
3M+46.3%-18.1%+64.3%+52.9%
6M+305.2%+33.2%+272.0%+228.1%
YTD+561.2%+49.5%+511.8%+399.9%
1Y+772.1%+55.1%+717.0%+547.3%
3Y+147.0%+113.5%+33.4%+47.2%
All-31.0%+104.1%-135.1%-58.1%

Cumulative growth

Daily Returns

Daily percentage return beside NTAP.

Daily Out/Under-Performance

Portfolio return minus NTAP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling